Market Access What rare disease commercialisation in Europe teaches us - a... Rare disease launches are the ultimate stress test for European commercialisation.
Sales & Marketing Sponsored Company Profile – POA Pharma In a landscape shaped by regulatory complexity, POA Pharma is demonstrating that smart, regionally tailored growth can outperform scale.
Market Access Why impactful and scalable global Medical Information (MI) p... A trusted MI partner ensures compliance with global and local regulations and provides consistent access to accurate medical information.
Digital Sovereign AI as the backbone of LSHC GCC innovation: Priorit... In recent times, Global Capability Centres (GCCs) have become drivers of innovation for global Life Sciences and Healthcare (LSHC) companies.
Sales & Marketing Sponsored Solution Spotlight: Viseven’s eWizard With the right process and tools, localisation can become a well-oiled machine.
Sales & Marketing Sponsored How to harmonise global content strategies with local needs ... Any pharma business operating on a global scale would naturally strive to execute a uniformed content marketing strategy across all markets.
News Pulmonary fibrosis drug developer Avalyn files IPO Avalyn Pharma hops on the IPO train, filing to list on the Nasdaq and raise funds for late-stage trials of its inhaled pulmonary fibrosis therapies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
